Development of assay flu virus

Ended Definitive Contract Awarded Last action

Contract number
HHSD200201689243C
Awardee
Awarding agency
Obligated
$14,121,107

Award facts

Opportunity
Contract value 6% obligated
  • $41,732,482.31 Current, with exercised options
  • $229,734,110.01 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Columbus, OH 43201, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 20 $0
Supplemental Agreement for work within scope 19 $133,839
Other Administrative Action 18 $0
Other Administrative Action 17 $0
Supplemental Agreement for work within scope 16 $519,255
Exercise an Option 15 $2,487,407
Funding Only Action 14 $2,412,302
Supplemental Agreement for work within scope 13 $0
Funding Only Action 12 $1,180,642
Exercise an Option 11 $1,180,642
Supplemental Agreement for work within scope 10 $18,984
Supplemental Agreement for work within scope 9 $0
Supplemental Agreement for work within scope 8 $730,358
Supplemental Agreement for work within scope 7 $1,259,112
Supplemental Agreement for work within scope 6 $0
Supplemental Agreement for work within scope 5 $0
Exercise an Option 4 $1,975,949
Change Order 3 $365,975
Supplemental Agreement for work within scope 2 $0
Other Administrative Action 1 $0
Original award $1,856,643
Show all 21

About this award

This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Battelle Memorial Institute, a nonprofit research and development organization, for the development of an assay for influenza virus. The $229,734,110.01 contract has a cost-plus-fixed-fee pricing type and an ultimate completion date of January 17, 2022. Battelle has subcontracted a portion of the work to Diagnostic Consulting Network, LLC (DCN Diagnostics), a for-profit limited liability company, to design, test, develop, and manufacture a rapid field influenza immunity test. This contract does not have a set-aside designation. Battelle frequently serves as a prime contractor for the U.S. government, leveraging its extensive scientific and technical capabilities to address complex challenges across various domains, including defense, homeland security, health, and energy.

Quick answers

Who was awarded contract HHSD200201689243C?

HHSD200201689243C was awarded to Battelle Memorial Institute by CDC Pittsburgh (Centers for Disease Control and Prevention) on July 18, 2016.

How much is contract HHSD200201689243C worth?

The government has obligated $14,121,107 on HHSD200201689243C. Its current value, with exercised options, is $41,732,482. Its potential value, with all options, is $229,734,110.

Was contract HHSD200201689243C competed?

The extent of competition for HHSD200201689243C was full and open competition. The government received 4 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award